Skip to main content
Oxford University Press logoLink to Oxford University Press
. 2025 Apr 2;193(1):173–175. doi: 10.1093/bjd/ljaf092

Characteristics of patients seeking skin-related minor ailment pharmacy services in Ontario, Canada: a population-based cross-sectional study

Rita J Iskandar 1,2,✉,b, Mina Tadrous 3,4, Paul Nguyen 5, Lisa Dolovich 6, Michael Green 7, Eliot Frymire 8, Aaron M Drucker 9,10
PMCID: PMC12192479  PMID: 40172112

Abstract

As healthcare systems are increasingly strained, policymakers in various jurisdictions have turned to pharmacies to offload services to treat minor ailments. These services were recently implemented in Ontario, Canada’s largest province, with 7 of 19 eligible minor ailments being skin conditions. In this letter, we provide the first description of the initial uptake of this new service for skin conditions, describing its users and how they compare with the general population of Ontario. Our findings show high utilization, highlighting the growing role of pharmacy-based skin services. Users tend to already be strongly connected to the healthcare system, suggesting potential disparities in access. These insights offer valuable guidance for policymakers as they refine and expand such programmes.


Dear Editor, To provide accessible, cost-effective care for common conditions and reduce healthcare system strain, the government of Ontario, Canada, introduced pharmacist prescribing for minor ailments in January 2023.1 This initiative parallels a wider trend, such as in the UK, where pharmacist-based minor ailment schemes have been implemented for > 15 years,2 and continue to evolve, most recently with the launch of the Pharmacy First service in England.3

Ontario pharmacists are currently authorized to assess and treat 19 minor ailments, 7 of which are skin-related.4 However, the actual utilization of pharmacy services for skin conditions has not been described. In this study, we describe the initial utilization of Ontario’s newly introduced pharmacist-led minor ailment services for skin conditions and compare patients using the services with the general population of Ontario.

We conducted a population-based cross-sectional study using Ontario’s administrative health data, linked using unique encoded identifiers and analysed at ICES.5 The study population consisted of Ontario residents eligible for the Ontario Health Insurance Plan (i.e. eligible for minor ailment services). We linked the Registered Persons Database (sociodemographic data), to these databases: (i) Ontario Drug Benefit (prescription data, including minor ailment service claims);6 (ii) Ontario Health Insurance Plan Claims (physician visits and associated diagnostic codes); (iii) Canadian Institute for Health Information National Ambulatory Record System, Discharge Abstract Database and Same Day Surgery (hospital-based care); and (iv) Primary Care Population (primary care attachment data).7

We determined the characteristics of patients who received pharmacy services for any of the five skin-related minor ailments introduced in January 2023: (i) dermatitis; (ii) herpes labialis (cold sores); (iii) impetigo; (iv) insect bites and urticaria (hives); and (v) tick bites (postexposure prophylaxis to prevent Lyme disease). Mild acne and diaper dermatitis were authorized later in the programme (October 2023) and were not included here.4 We calculated descriptive statistics for patients using the services, and for the entire eligible Ontario population as a reference. All variables were categorical. We conducted analyses using SAS 9.4M8 (SAS Institute, Cary, NC, USA).

Between 1 January and 31 December 2023, minor ailment services were accessed by 547 673 patients in Ontario. Of these, 112 718 (21%) were for the five skin-­related conditions, with 85% (n = 96 109) receiving a prescription from a pharmacist. Dermatitis (35%; n = 39 365) and herpes labialis (41%; n = 46 659) were the most common skin conditions for which pharmacy services were sought.

Adults aged 35–64 years were the largest age group overall to receive skin-related services (47%; n = 53 302/112 718), particularly for dermatitis and herpes labialis [41% (n = 16 292) and 57% (n = 26 704), respectively]. Female patients comprised 62% (n = 70 290) of those receiving skin-related services, with the highest proportion observed for herpes labialis (71%; n = 33 274); for comparison, Ontario’s population has a more balanced sex distribution (51% female; n = 7 797 071/15 422 607). Urban residents accounted for 70% (n = 79 203) of users, aligned with Ontario’s population (73% urban; n = 11 198 499). Most patients (90%; n = 101 283) were attached to primary care, a somewhat higher proportion than the eligible population’s attachment (85%; n = 13 060 990). High healthcare resource utilization overall was more common among pharmacy service users than it was among the general population [25% (n = 28 282) vs. 19% (n = 2 859 053)]. Users also more commonly had a higher socioeconomic position than the general population [45% (n = 51 140) vs. 41% (n = 6 222 636)]. Living in the highest quintile of racialized and newcomer neighbourhoods was somewhat under-represented among pharmacy services users vs. the general population [46% (n = 51 833) vs. 51% (n = 7 824 809)] (Table 1).

Table 1.

Characteristics of patients receiving skin-related minor ailment pharmacy services and the general population in Ontario in 2023

Skin-related minor ailment services Residents of Ontarioa
Characteristicb Total Dermatitisc Herpes labialis Impetigo Insect bites and urticaria Tick bitesd Total
Overall (row %) 112 718 (100) 39 365 (35) 46 659 (41) 7238 (6) 7587 (7) 13 862 (12) 15 422 607 (100)
Issued a prescriptione 96 109 (85) 32 060 (81) 42 521 (91) 6363 (88) 5128 (68) 11 616 (84) NA
Attached to primary caref 101 283 (90) 34 921 (89) 42 020 (90) 6493 (90) 6863 (91) 12 786 (92) 13 060 990 (85)
Age group (years)
 < 18 12 674 (11) 5355 (14) 1519 (3) 3161 (44) 1100 (15) 1713 (13) 3 048 659 (20)
 19–34 24 286 (22) 8194 (21) 12 411 (27) 1135 (16) 1243 (16) 1689 (12) 3 351 881 (22)
 35–64 53 302 (47) 16 292 (41) 26 704 (57) 1912 (26) 3110 (41) 6278 (45) 6 181 181 (40)
 > 65 22 456 (20) 9524 (24) 6025 (13) 1030 (14) 2134 (28) 4182 (30) 2 840 886 (18)
Female sex 70 290 (62) 23 109 (59) 33 274 (71) 3991 (55) 4932 (65) 6295 (45) 7 797 071 (51)
Urban settingg,h 79 203 (70) 30 093 (76) 34 825 (75) 4577 (63) 5635 (74) 5551 (40) 11 198 499 (73)
High resource utilizationi 28 282 (25) 10 344 (26) 11 985 (26) 1591 (22) 2100 (28) 2865 (21) 2 859 053 (19)
Income quintileg,j
 1 (lowest)–2 39 129 (35) 15 895 (41) 14 799 (32) 2610 (36) 2884 (38) 3702 (27) 6 033 382 (39)
 3 22 194 (20) 7595 (19) 9032 (19) 1411 (20) 1447 (19) 3080 (22) 3 128 034 (20)
 4–5 (highest) 51 140 (45) 15 785 (40) 22 714 (49) 3198 (44) 3231 (43) 7061 (51) 6 222 636 (41)
Racialized and newcomer populations quintileg,k
 1 (lowest)–2 39 505 (35) 10 861 (28) 14 192 (30) 3048 (43) 2389 (32) 9600 (70) 4 813 780 (32)
 3 20 800 (19) 6688 (17) 9582 (21) 1383 (19) 1385 (18) 2102 (15) 2 657 488 (17)
 4–5 (highest) 51 833 (46) 21 601 (55) 22 681 (49) 2739 (38) 3755 (50) 2109 (15) 7 824 809 (51)

Data are presented as n (%). NA, not applicable. aIndividuals in the Registered Persons Database as of 31 March 2023 (i.e., those who have an Ontario Health Insurance Plan card number). bPercentages are column percentages, unless otherwise specified. cBroadly includes atopic, allergic, contact dermatitis and eczema. dIncludes postexposure prophylaxis to prevent Lyme disease. eThe community pharmacist can issue a prescription or not. Patients who were assessed but not issued a prescription may not have required one, were recommended an over-the-counter medication or were referred for assessment by a physician. fIn-person or virtually rostered to a primary care physician or accessed a community health centre in the past 2 years (i.e. regular source of primary care access). gLess than 1.5% missing data among those variables that used the postal code data. hRurality Index for Ontario (RIO) score < 10. iJohns Hopkins ACG® System Version 10.0.1 High Healthcare Resource Utilization Bands (RUBs) > 4. jNeighbourhood income quintiles based on the neighbourhood ranking of average household income within each census metropolitan area or census agglomeration. kHigh area-level measure of recent immigrants in the past 5 years and those who self-identify as a visible minority (as defined by Statistics Canada).

In this study of Ontario’s new pharmacy service for skin conditions, we found relatively high overall utilization and prescribing, suggesting significant demand for minor ailment services in pharmacies. We also observed higher utilization by already well-integrated healthcare users, rather than people who otherwise have limited primary care ­physician-based access. One rationale for the ­pharmacy-based minor ailments service is to engage a large portion of the population in need of treatment for minor conditions, specifically people with limited primary care physician-based access. Our findings suggest disparities in initial utilization not aligned with those goals. The comparison of users with the general eligible population suggests other potential differences in utilization across various demographics. For instance, the representation of users for skin-related services appears to be lower among rural residents, younger patients, those from lower-income households and those from racialized and newcomer neighbourhoods.

Use of Ontario’s skin-related minor ailments service in its first year suggests a strong demand for these services that was not being met in primary care. However, the observed disparities in access indicate that targeted improvements to better align the service with its intended goals are warranted. It will be valuable for Ontario and other jurisdictions to continually monitor and evaluate these trends and the long-term impact of the pharmacy minor ailments programme for skin conditions, particularly as the service expands to include additional conditions.

Acknowledgements

This document used data adapted from the Statistics Canada Postal CodeOM Conversion File, which is based on data licensed from Canada Post Corporation, and/or data adapted from the Ontario Ministry of Health Postal Code Conversion File, which contains data copied under license from ©Canada Post Corporation and Statistics Canada. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI) and the Ontario Ministry of Health. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. We would like to thank the Toronto Community Health Profiles Partnership for providing access to the Ontario Marginalization Index.

Contributor Information

Rita J Iskandar, Department of Medicine and Women’s College Research and Innovation Institute, Women’s College Hospital, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

Mina Tadrous, Department of Medicine and Women’s College Research and Innovation Institute, Women’s College Hospital, Toronto, ON, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

Paul Nguyen, ICES Queen’s, Queen’s University, Kingston, ON, Canada.

Lisa Dolovich, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

Michael Green, Health Services and Policy Research Institute, Queen’s University, Kingston, ON, Canada.

Eliot Frymire, Health Services and Policy Research Institute, Queen’s University, Kingston, ON, Canada.

Aaron M Drucker, Department of Medicine and Women’s College Research and Innovation Institute, Women’s College Hospital, Toronto, ON, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Funding sources

This study was supported by the Innovations Strengthening Primary Health Care through Research (INSPIRE PHC) programme, which was funded by the Ontario Ministry of Health and Long-Term Care (MOHLTC), and by a Network for Improving Health Systems New Initiative and Innovation Award (NIHS NIIA) from the University of Toronto Leslie Dan Faculty of Pharmacy and Dalla Lana School of Public Health. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and MOHLTC. R.J.I. was supported by the PASSERELLE Patient-Oriented Research-Mitacs Fellowship (IT40614). PASSERELLE, the National Training Entity for Patient-Oriented Research (POR), is supported by the Canadian Institutes of Health Research (CIHR) under Canada’s Strategy for Patient-Oriented Research (SPOR) Initiative. The funders had no role in the study design, data analysis, interpretation of results, manuscript preparation or publication decision.

Data availability

Data-sharing agreements prohibit ICES from making the data publicly available, but access may be granted to those who meet prespecified criteria for confidential access (available at: https://www.ices.on.ca/DAS).

Ethics statement

ICES is an independent, nonprofit research institute whose legal status under Ontario’s health information privacy law allows it to collect and analyse healthcare and demographic data, without consent, for health system evaluation and improvement. The use of the data in this project is authorized under section 45 of Ontario’s Personal Health Information Protection Act (PHIPA) and does not require review by a Research Ethics Board.

Patient consent

Not applicable.

References

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data-sharing agreements prohibit ICES from making the data publicly available, but access may be granted to those who meet prespecified criteria for confidential access (available at: https://www.ices.on.ca/DAS).


Articles from The British Journal of Dermatology are provided here courtesy of Oxford University Press

RESOURCES